Millar is pleased to announce a new collaboration agreement with APAC Scientific as a continuation of its strategic expansion into Asia Pacific (APAC).
Through this agreement, a Sydney, Australia office will be established to enable the direct sale of Millar’s innovative Life Science Telemetry System and to facilitate the sale of the Mikro-CathTM cardiovascular pressure catheter into approved countries in the region.
Sydney is an ideal location to deliver enhanced, local support to regional Millar customers and distributors while also establishing relationships with key regional opinion leaders. This will accelerate the adoption of Millar Telemetry Systems to enable new scientific discoveries within the APAC region and allow Millar to reach clinical influencers interested in expanding medical understanding through globally recognized clinical product offerings.
“We are excited to take this next step in the Company’s plans for the Asia Pacific region as it will continue to play a greater role in Millar’s future. We look forward to providing a higher level of support to our customers and business partners, and I am confident that APAC Scientific will represent the Millar brand with excellence and integrity,” said Tim Daugherty, president and CEO at Millar.
Millar’s expansion into this region began with the establishment of its first international office following the 2011 merger with Telemetry Research in Auckland, New Zealand. The Millar New Zealand office will remain a focused Innovation Hub that leverages the long-standing relationship with the University of Auckland’s Bioengineering Institute for innovative product development to support the company’s strategic R&D efforts.